Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-25 @ 6:59 PM
NCT ID: NCT04996004
Term: Alopecia
Organ System: Skin and subcutaneous tissue disorders
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA v26.1
Notes: None
Study: NCT04996004
Study Brief: A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG004 None 2 13 View
EG000 None 1 3 View
EG001 None 0 3 View
EG002 None 0 3 View
EG003 None 13 32 View
EG005 None 12 22 View